Treatment of cocaine withdrawal anxiety with guanfacine: relationships to cocaine intake and reinstatement of cocaine seeking in rats

[1]  Janet B W Williams,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[2]  G. Aston-Jones,et al.  α2 Adrenergic and Imidazoline Receptor Agonists Prevent Cue-Induced Cocaine Seeking , 2011, Biological Psychiatry.

[3]  TF Newton A Perhaps Unexpected Role of Norepinephrine in Actions of MDMA , 2011, Clinical pharmacology and therapy.

[4]  Udi E. Ghitza,et al.  Clonidine blocks stress-induced craving in cocaine users , 2011, Psychopharmacology.

[5]  Y. Shaham,et al.  Effect of prazosin and guanfacine on stress-induced reinstatement of alcohol and food seeking in rats , 2011, Psychopharmacology.

[6]  B. Everitt,et al.  Selective Norepinephrine Reuptake Inhibition by Atomoxetine Prevents Cue-Induced Heroin and Cocaine Seeking , 2011, Biological Psychiatry.

[7]  P. Holmes,et al.  Disulfiram Attenuates Drug-Primed Reinstatement of Cocaine Seeking via Inhibition of Dopamine β-Hydroxylase , 2010, Neuropsychopharmacology.

[8]  M. Marinelli,et al.  Persistent Increases in Cocaine-Seeking Behavior After Acute Exposure to Cold Swim Stress , 2010, Biological Psychiatry.

[9]  S. Erb Evaluation of the relationship between anxiety during withdrawal and stress-induced reinstatement of cocaine seeking , 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[10]  S. Back,et al.  Yohimbine stress potentiates conditioned cue-induced reinstatement of heroin-seeking in rats , 2010, Behavioural Brain Research.

[11]  R. Sterling,et al.  Cocaine withdrawal‐induced anxiety in females: Impact of circulating estrogen and potential use of delta‐opioid receptor agonists for treatment , 2009, Journal of neuroscience research.

[12]  D. Buffalari,et al.  Inactivation of the bed nucleus of the stria terminalis in an animal model of relapse: effects on conditioned cue-induced reinstatement and its enhancement by yohimbine , 2010, Psychopharmacology.

[13]  D. Buffalari,et al.  Footshock stress potentiates cue-induced cocaine-seeking in an animal model of relapse , 2009, Physiology & Behavior.

[14]  C. Dackis,et al.  Predictors of treatment outcome in outpatient cocaine and alcohol dependence treatment. , 2009, The American journal on addictions.

[15]  M. Lapiz-Bluhm,et al.  Behavioural Assays to Model Cognitive and Affective Dimensions of Depression and Anxiety in Rats , 2008, Journal of neuroendocrinology.

[16]  A. Waters,et al.  Disulfiram enhances subjective effects of dextroamphetamine in humans , 2008, Pharmacology Biochemistry and Behavior.

[17]  G. Aston-Jones,et al.  Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinence , 2008, Brain Structure and Function.

[18]  F. Weiss,et al.  Rats with Extended Access to Cocaine Exhibit Increased Stress Reactivity and Sensitivity to the Anxiolytic-Like Effects of the mGluR 2/3 Agonist LY379268 during Abstinence , 2008, Neuropsychopharmacology.

[19]  L. Hays,et al.  Safety, tolerability and subject-rated effects of acute intranasal cocaine administration during atomoxetine maintenance. , 2008, Drug and alcohol dependence.

[20]  D. Baker,et al.  Stressor- and corticotropin releasing factor-induced reinstatement and active stress-related behavioral responses are augmented following long-access cocaine self-administration by rats , 2007, Psychopharmacology.

[21]  R. Spealman,et al.  Noradrenergic Mechanisms in Cocaine-Induced Reinstatement of Drug Seeking in Squirrel Monkeys , 2007, Journal of Pharmacology and Experimental Therapeutics.

[22]  E. V. Bockstaele,et al.  Betaxolol, a selective beta(1)-adrenergic receptor antagonist, diminishes anxiety-like behavior during early withdrawal from chronic cocaine administration in rats. , 2007, Progress in neuro-psychopharmacology & biological psychiatry.

[23]  A. Preti REVIEW: New developments in the pharmacotherapy of cocaine abuse , 2007, Addiction biology.

[24]  Thomas R Kosten,et al.  Treatment Outcome Predictors for Cocaine Dependence , 2007, The American journal of drug and alcohol abuse.

[25]  C. Dackis,et al.  Outcome predictors in cocaine dependence treatment trials. , 2006, The American journal on addictions.

[26]  K. Lynch,et al.  A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms. , 2006, Drug and alcohol dependence.

[27]  R. See,et al.  Potentiation of cue-induced reinstatement of cocaine-seeking in rats by the anxiogenic drug yohimbine , 2006, Behavioural Brain Research.

[28]  R. A. Fuchs,et al.  Contributions of prolonged contingent and noncontingent cocaine exposure to enhanced reinstatement of cocaine seeking in rats , 2006, Psychopharmacology.

[29]  T. Kosten,et al.  Emerging pharmacological strategies in the fight against cocaine addiction , 2006, Expert opinion on emerging drugs.

[30]  M. Filip,et al.  Conditioned rewarding stimulus associated with cocaine self-administration reverses the depression of catecholamine brain systems following cocaine withdrawal in rats. , 2005, The international journal of neuropsychopharmacology.

[31]  D. Hatsukami,et al.  The effect of individual cocaine withdrawal symptoms on outcomes in cocaine users. , 2005, Addictive behaviors.

[32]  X. Zhang,et al.  Prazosin, an α-1 Adrenergic Antagonist, Reduces Cocaine-Induced Reinstatement of Drug-Seeking , 2005, Biological Psychiatry.

[33]  Michael A. Nader,et al.  Effects of chronic cocaine self-administration on norepinephrine transporters in the nonhuman primate brain , 2005, Psychopharmacology.

[34]  G. Aston-Jones,et al.  β-adrenergic antagonists attenuate withdrawal anxiety in cocaine-and morphine-dependent rats , 2005, Psychopharmacology.

[35]  X. Zhang,et al.  Prazosin, an alpha-1 adrenergic antagonist, reduces cocaine-induced reinstatement of drug-seeking. , 2005, Biological psychiatry.

[36]  R. Rothman,et al.  Evidence for alterations in α2-adrenergic receptor sensitivity in rats exposed to repeated cocaine administration , 2004, Neuroscience.

[37]  Gary Aston-Jones,et al.  Brain substrates for increased drug seeking during protracted withdrawal , 2004, Neuropharmacology.

[38]  R. A. Fuchs,et al.  Differential Involvement of Orbitofrontal Cortex Subregions in Conditioned Cue-Induced and Cocaine-Primed Reinstatement of Cocaine Seeking in Rats , 2004, The Journal of Neuroscience.

[39]  Y. Shaham,et al.  The anxiogenic drug yohimbine reinstates methamphetamine seeking in a rat model of drug relapse , 2004, Biological Psychiatry.

[40]  B. Rounsaville,et al.  Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial. , 2004, Archives of general psychiatry.

[41]  H. Covington,et al.  Vocalizations during withdrawal from opiates and cocaine: possible expressions of affective distress. , 2003, European journal of pharmacology.

[42]  T. Kosten,et al.  Prediction of Treatment Outcome by Baseline Urine Cocaine Results and Self‐Reported Cocaine Use for Cocaine and Opioid Dependence , 2003, The American journal of drug and alcohol abuse.

[43]  D. Morilak,et al.  Modulatory effects of norepinephrine, acting on alpha1 receptors in the central nucleus of the amygdala, on behavioral and neuroendocrine responses to acute immobilization stress , 2002, Neuropharmacology.

[44]  F. Leri,et al.  Blockade of Stress-Induced But Not Cocaine-Induced Reinstatement by Infusion of Noradrenergic Antagonists into the Bed Nucleus of the Stria Terminalis or the Central Nucleus of the Amygdala , 2002, The Journal of Neuroscience.

[45]  D. Morilak,et al.  Modulatory effects of norepinephrine in the lateral bed nucleus of the stria terminalis on behavioral and neuroendocrine responses to acute stress , 2002, Neuroscience.

[46]  R. Sinha How does stress increase risk of drug abuse and relapse? , 2001, Psychopharmacology.

[47]  Y. Shaham,et al.  Repeated Lofexidine Treatment Attenuates Stress-Induced, But not Drug Cues-Induced Reinstatement of a Heroin-Cocaine Mixture (Speedball) Seeking in Rats , 2001, Neuropsychopharmacology.

[48]  A. Cnaan,et al.  Effectiveness of propranolol for cocaine dependence treatment may depend on cocaine withdrawal symptom severity. , 2001, Drug and alcohol dependence.

[49]  Rosemarie A. Martin,et al.  The Relationship Between Anxiety Levels and Outcome of Cocaine Abuse Treatment , 2000, The American journal of drug and alcohol abuse.

[50]  G. Koob,et al.  Corticotropin-releasing factor antagonist attenuates the “anxiogenic-like” effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats , 1999, Psychopharmacology.

[51]  K. Bucholz,et al.  Clinical implications for four drugs of the DSM-IV distinction between substance dependence with and without a physiological component. , 1999, The American journal of psychiatry.

[52]  A. Pert,et al.  Conditioned release of corticosterone by contextual stimuli associated with cocaine is mediated by corticotropin-releasing factor , 1998, Brain Research.

[53]  H. Intengan,et al.  Alpha-2a/d adrenoceptor subtype stimulation by guanfacine increases osmolar clearance. , 1997, The Journal of pharmacology and experimental therapeutics.

[54]  J. Nobrega,et al.  Changes in serotonin and norepinephrine uptake sites after chronic cocaine: pre- vs. post-withdrawal effects , 1996, Brain Research.

[55]  Z. Sarnyai,et al.  Brain corticotropin-releasing factor mediates ‘anxiety-like’ behavior induced by cocaine withdrawal in rats , 1995, Brain Research.

[56]  C. McDougle,et al.  Noradrenergic dysregulation during discontinuation of cocaine use in addicts. , 1994, Archives of general psychiatry.

[57]  Y. K. Fung,et al.  Behavioural consequences of cocaine withdrawal in rats , 1994, The Journal of pharmacy and pharmacology.

[58]  G. Aston-Jones,et al.  Beta-adrenergic antagonists attenuate withdrawal anxiety in cocaine- and morphine-dependent rats. , 1993, Psychopharmacology.

[59]  A. Gorman,et al.  Anxiogenic effects of acute and chronic cocaine administration: Neurochemical and behavioral studies , 1992, Pharmacology Biochemistry and Behavior.

[60]  J. Wikberg,et al.  Delineation of rat kidney α2A- and α2B-adrenoeeptors with [3H]RX821002 radiollgand binding: computer modelling reveals that guanfacine is an α2A-selective compound , 1991 .

[61]  J. Wikberg,et al.  Delineation of rat kidney alpha 2A- and alpha 2B-adrenoceptors with [3H]RX821002 radioligand binding: computer modelling reveals that guanfacine is an alpha 2A-selective compound. , 1991, European journal of pharmacology.

[62]  S. File,et al.  Validation of open : closed arm entries in an elevated plus-maze as a measure of anxiety in the rat , 1985, Journal of Neuroscience Methods.

[63]  D. Treit Burying as a defensive response in rats , 1978 .